Literature DB >> 3115902

Plasma levels of leukotrienes C4 and D4 during wheezing attack in asthmatic patients.

T Okubo1, H Takahashi, M Sumitomo, K Shindoh, S Suzuki.   

Abstract

To study a role of leukotrienes (LTs) in bronchial asthma, we measured LTC4 and LTD4 in plasma of 16 asthmatics during wheezing attack and of 4 normal subjects. Plasma of arterial blood was processed by extraction using the SEP-PAK, followed by high-performance liquid chromatography (HPLC). Fractions from HPLC with elution times which corresponded to synthetic LTC4 and LTD4 were used for quantification of LTs by radioimmunoassay (RIA) and bioassay. LTC4 was detected in 13 out of 16 asthmatics by RIA (mean +/- SD, 410 +/- 630 pg/ml) and in 5 by bioassay. LTD4 was detected in 10 out of 16 asthmatics by RIA (mean +/- SD, 540 +/- 290 pg/ml) and in 7 by bioassay. No LTs were detected by either method in the normal subjects. The present study shows that LTC4 and LTD4 play a role as chemical mediators during asthmatic attack.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115902     DOI: 10.1159/000234414

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  8 in total

1.  Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.

Authors:  Y Nakamura; M Hoshino; J J Sim; K Ishii; K Hosaka; T Sakamoto
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

Review 2.  Leukotriene activity modulation in asthma.

Authors:  S L Spector
Journal:  Drugs       Date:  1997-09       Impact factor: 9.546

Review 3.  Leukotriene receptor antagonists: clinical effects.

Authors:  N Barnes
Journal:  J R Soc Med       Date:  1997-04       Impact factor: 5.344

Review 4.  LTC4 synthase. Enzymology, biochemistry, and molecular characterization.

Authors:  J F Penrose
Journal:  Clin Rev Allergy Immunol       Date:  1999 Spring-Summer       Impact factor: 8.667

5.  Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on antigen-induced airway responses in neonatally immunized rabbits.

Authors:  C M Herd; D Donigi-Gale; T S Shoupe; D A Burroughs; M Yeadon; C P Page
Journal:  Br J Pharmacol       Date:  1994-05       Impact factor: 8.739

Review 6.  Leukotrienes as a target in asthma therapy.

Authors:  N Chanarin; S L Johnston
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

Review 7.  Leukotriene and thromboxane antagonists.

Authors:  T Obata; N Yamashita; T Nakagawa
Journal:  Clin Rev Allergy       Date:  1994

Review 8.  Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases.

Authors:  Francesca Colazzo; Paolo Gelosa; Elena Tremoli; Luigi Sironi; Laura Castiglioni
Journal:  Mediators Inflamm       Date:  2017-08-28       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.